Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis

ClinicalTrials.gov ID: NCT02696785

Public ClinicalTrials.gov record NCT02696785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 3:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biological disease-modifying anti-rheumatic drugs (bDMARDs)-naive participants with radiographic axial spondyloarthritis (rad-axSpA).

Study identification

NCT ID
NCT02696785
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
341 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 1, 2016
Primary completion
Dec 7, 2017
Completion
Oct 16, 2018
Last update posted
Nov 18, 2019

2016 – 2018

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Arizona Arthritis Research, PLC Phoenix Arizona 85032
Care Access Research - Huntington Beach Huntington Beach California 92648
Desert Medical Advances Palm Desert California 92260
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC Colorado Springs Colorado 80920
Denver Arthritis Center Denver Colorado 80230
New England Research Associates Trumbull Connecticut 06611
Sarasota Arthritis Center Sarasota Florida 34239
Marietta Rheumatology Marietta Georgia 30060
Center for Arthritis & Osteoporosis Elizabethtown Kentucky 42701
Klein and Associates MD, PA Cumberland Maryland 21502
Klein and Associates MD, PA Hagerstown Maryland 21740
Arthritis Consultants St Louis Missouri 63141
Glacier View Research Institute Kalispell Montana 59901
Physician Research Collaboration, LLC Lincoln Nebraska 68516
Shanahan Rheumatology & Immunotherapy Raleigh North Carolina 27617
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr Columbia South Carolina 29204
Low Country Research Center North Charleston South Carolina 29406
Univ of Texas Health Science Center - Houston Houston Texas 77030
Arthritis Northwest Rheumatology Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02696785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2019 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02696785 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →